Transformable liquid-metal nanomedicine
Open Access
- 2 December 2015
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Communications
- Vol. 6 (1), 10066
- https://doi.org/10.1038/ncomms10066
Abstract
To date, numerous inorganic nanocarriers have been explored for drug delivery systems (DDSs). However, the clinical application of inorganic formulations has often been hindered by their toxicity and failure to biodegrade. We describe here a transformable liquid-metal nanomedicine, based on a core–shell nanosphere composed of a liquid-phase eutectic gallium-indium core and a thiolated polymeric shell. This formulation can be simply produced through a sonication-mediated method with bioconjugation flexibility. The resulting nanoparticles loaded with doxorubicin (Dox) have an average diameter of 107 nm and demonstrate the capability to fuse and subsequently degrade under a mildly acidic condition, which facilitates release of Dox in acidic endosomes after cellular internalization. Equipped with hyaluronic acid, a tumour-targeting ligand, this formulation displays enhanced chemotherapeutic inhibition towards the xenograft tumour-bearing mice. This liquid metal-based DDS with fusible and degradable behaviour under physiological conditions provides a new strategy for engineering theranostic agents with low toxicity.Keywords
This publication has 37 references indexed in Scilit:
- Defining Rules for the Shape Evolution of Gold NanoparticlesJournal of the American Chemical Society, 2012
- Three-Dimensional, Flexible Nanoscale Field-Effect Transistors as Localized BioprobesScience, 2010
- Design considerations for tumour-targeted nanoparticlesNature Nanotechnology, 2009
- Dumbbell-like Au−Fe3O4 Nanoparticles for Target-Specific Platin DeliveryJournal of the American Chemical Society, 2009
- Multifunctional Inorganic Nanoparticles for Imaging, Targeting, and Drug DeliveryACS Nano, 2008
- Nanocarriers as an emerging platform for cancer therapyNature Nanotechnology, 2007
- Renal clearance of quantum dotsNature Biotechnology, 2007
- Self-Assembled Monolayers of Thiolates on Metals as a Form of NanotechnologyChemical Reviews, 2005
- Gallium in cancer treatmentCritical Reviews in Oncology/Hematology, 2002
- CD44 is the principal cell surface receptor for hyaluronateCell, 1990